title: Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
authors.forename: A John
authors.initials: AJ
authors.lastname: Camm
authors.forename: Paulus
authors.initials: P
authors.lastname: Kirchhof
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
authors.forename: Ulrich
authors.initials: U
authors.lastname: Schotten
authors.forename: Irene
authors.initials: I
authors.lastname: Savelieva
authors.forename: Sabine
authors.initials: S
authors.lastname: Ernst
authors.forename: Isabelle C
authors.initials: IC
authors.lastname: Van Gelder
authors.forename: Nawwar
authors.initials: N
authors.lastname: Al-Attar
authors.forename: Gerhard
authors.initials: G
authors.lastname: Hindricks
authors.forename: Bernard
authors.initials: B
authors.lastname: Prendergast
authors.forename: Hein
authors.initials: H
authors.lastname: Heidbuchel
authors.forename: Ottavio
authors.initials: O
authors.lastname: Alfieri
authors.forename: Annalisa
authors.initials: A
authors.lastname: Angelini
authors.forename: Dan
authors.initials: D
authors.lastname: Atar
authors.forename: Paolo
authors.initials: P
authors.lastname: Colonna
authors.forename: Raffaele
authors.initials: R
authors.lastname: De Caterina
authors.forename: Johan
authors.initials: J
authors.lastname: De Sutter
authors.forename: Andreas
authors.initials: A
authors.lastname: Goette
authors.forename: Bulent
authors.initials: B
authors.lastname: Gorenek
authors.forename: Magnus
authors.initials: M
authors.lastname: Heldal
authors.forename: Stefan H
authors.initials: SH
authors.lastname: Hohloser
authors.forename: Philippe
authors.initials: P
authors.lastname: Kolh
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Le Heuzey
authors.forename: Piotr
authors.initials: P
authors.lastname: Ponikowski
authors.forename: Frans H
authors.initials: FH
authors.lastname: Rutten
mesh_terms: D054058:Acute Coronary Syndrome / Q000453:epidemiology / Q000628:therapy; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D056352:Athletes / Q000706:statistics & numerical data; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D002312:Cardiomyopathy, Hypertrophic / Q000453:epidemiology; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000453:epidemiology; D004554:Electric Countershock / Q000295:instrumentation / Q000379:methods; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000453:epidemiology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006349:Heart Valve Diseases / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006980:Hyperthyroidism / Q000453:epidemiology; D008171:Lung Diseases / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D015995:Prevalence; D014927:Wolff-Parkinson-White Syndrome / Q000453:epidemiology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D010975:Platelet Aggregation Inhibitors